[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334430-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334430-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","high-inos-and-il-1-immunoreactivity-are-features-of-colitis-associated-colorectal-cancer-tumors-but-fail-to-predict-5-year-survival","High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival","","Inflammatory bowel disease (IBD) drives colitis-associated colorectal cancer (CAC), where inducible nitric oxide synthase (iNOS) activity increases luminal nitric oxide and iNOS is believed to parallel pro-inflammatory interleukin-1β (IL-1β). This study assessed iNOS and IL-1β immunoreactivity in CAC tumors versus sporadic CRC and normal colonic mucosa, and tested correlation with CAC 5-year survival. Immunohistochemistry quantified iNOS and IL-1β separately in epithelium and stroma; results were supported by online mRNA databases. Higher iNOS and IL-1β in CAC epithelium contrasted with lower iNOS but higher IL-1β in CAC stroma, and neither biomarker predicted 5-year outcome.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/high-inos-and-il-1-immunoreactivity-are-features-of-colitis-associated-colorectal-cancer-tumors-but-fail-to-predict-5-year-survival/334430/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/high-inos-and-il-1-immunoreactivity-are-features-of-colitis-associated-colorectal-cancer-tumors-but-fail-to-predict-5-year-survival/334430.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the primary aim of the study?","Question",{"text":63,"@type":64},"To investigate iNOS and IL-1β immunoreactivity in CAC tumors compared with sporadic CRC and normal colonic mucosa.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were iNOS and IL-1β quantified and analyzed?",{"text":68,"@type":64},"Immunohistochemistry quantified iNOS and IL-1β separately in epithelium and stroma, with Mann-Whitney U tests and log-rank tests for 5-year Kaplan-Meier survival curves.",{"name":70,"@type":61,"acceptedAnswer":71},"Did iNOS or IL-1β immunoreactivity predict 5-year survival in CAC patients?",{"text":72,"@type":64},"No. Differences in iNOS or IL-1β immunoreactivity among CAC patients failed to correlate with 5-year survival.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334430,1790648412,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":4},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","ORIGINAL RESEARCH ARTICLE  \nHigh iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival  \nKajsa Björnera, Wei-Na Chena, Venkata Ram Gannavarapua, Fredrik Axlingb, Miklos Gulyasc, Mohammad Abdul Halima, Dominic-Luc Webba† and Per M. Hellströma†  \na Department of Medical Sciences, Gastroenterology and Hepatology Section, Uppsala University, Uppsala, Sweden; bDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden; c Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden  \nABSTRACT  \nBackground: Inflammatory bowel disease (IBD; mainly ulcerative colitis and Crohn’s disease) is associated with the development of colorectal cancer (CRC) referred to as colitis-associated colorectal cancer (CAC) . In inflammatory flares of IBD, the production of luminal nitric oxide (NO) increases due to the increased inducible nitric oxide synthase (iNOS) activity in inflamed tissue. It is believed that iNOS parallels pro-inflammatory interleukin-1β (IL-1β) . How these biomarkers relate to CAC pathogenesis or survival is unknown. Aim: The primary aim of this study was to investigate iNOS and IL-1β immunoreactivity in CAC tumors in comparison with CRC and normal colonic mucosa, and the secondary aim was to determine if immunoreactivity correlates with 5-year survival of CAC.  \nMethods: Immunohistochemistry was performed on tissue sections as follows: CAC (n = 59); sporadic CRC (sCRC) (n = 12); colonic mucosa >2 cm outside sCRC margin (normal mucosa) (n = 22); paracancerous IBD (pIBD) (n = 12) . The expression of iNOS and IL-1β was quantified separately for epithelium and stroma. Data were evaluated using the Mann-Whitney U-test and the log-rank test for 5-year Kaplan-Meier survival curves. Results were compared with online mRNA databases.  \nResults: Immunoreactivity occurred predominantly in epithelial cells and to lesser extent in stroma. Compared with normal mucosa, immunoreactivity for iNOS (P \u003C 0.01) and IL-1β (P \u003C 0.005) was higher in CAC epithelium. In CAC stroma, iNOS immunoreactivity was lower than normal mucosa (P \u003C 0.001), whereas IL-1β was higher (P \u003C 0.05) . Immunoreactivity differences of iNOS or IL-1β among CAC patients failed to correlate with 5-year survival. These findings were supported by online mRNA databases.  \nConclusion: Consistent with high NO production in IBD, there is more iNOS in CAC epithelium, albeit not instroma. This immunoreactivity difference exists for IL-1β in both epithelium and stroma. The intervention of arginine or iNOS activity for CAC chemotherapy is not straightforward.  \nARTICLE HISTORY  \nReceived 21 September 2023 Revised 9 November 2023 Accepted 3 December 2023 Published 2 January 2024  \nKEYWORDS  \nColorectal cancer; colitisassociated colorectal cancer; Interleukin-1β; inducible nitric oxide synthase; inflammatory bowel disease; tumor biology  \nIntroduction  \nInflammatory bowel disease (IBD) has increased in Sweden over the past century. IBD is subdivided into ulcerative colitis (UC), Crohn’s disease (CD), and unclassified (IBD-U) . Data published a decade ago for the Uppsala region reported that yearly incidence of new cases of UC was 20/100 000, and that of CD was 9.9/100 000 (1, 2) . Since 1970, the total population here has steadily risen by 5–10% every 5 years and is currently~400 000, amounting to roughly 100 new IBD cases annually, some of whom went on to develop colorectal cancer (CRC) . IBDis associated with increased risk of CRC (3–6), justifying surveillance for cancer. Higher risk has been associated with  \nlong duration of IBD, extensive disease, active inflammation, and primary sclerosing cholangitis (PSC) (7–10) . For research purposes, IBD patients who develop CRC are subclassified as‘colitis-associated colorectal cancer’ (CAC) . Findings from epidemiological studies exploring parameters such as standardized mortality rate (SMR) in IBD vary but generally show higher mortali","cbCaigdPNrAxZsYH","https://ap.wps.com/l/cbCaigdPNrAxZsYH","pdf",770059,"English","# Abstract\n# Introduction\n## Inflammatory bowel disease and cancer risk\n## Nitric oxide and inflammatory signaling\n# Methods\n## Patient/tissue groups and immunohistochemistry\n## Statistical analysis and survival assessment\n## mRNA database comparison\n# Results\n## Epithelium versus stroma immunoreactivity patterns\n## Relationship to 5-year survival\n# Conclusion","[{\"question\":\"What was the primary aim of the study?\",\"answer\":\"To investigate iNOS and IL-1β immunoreactivity in CAC tumors compared with sporadic CRC and normal colonic mucosa.\"},{\"question\":\"How were iNOS and IL-1β quantified and analyzed?\",\"answer\":\"Immunohistochemistry quantified iNOS and IL-1β separately in epithelium and stroma, with Mann-Whitney U tests and log-rank tests for 5-year Kaplan-Meier survival curves.\"},{\"question\":\"Did iNOS or IL-1β immunoreactivity predict 5-year survival in CAC patients?\",\"answer\":\"No. Differences in iNOS or IL-1β immunoreactivity among CAC patients failed to correlate with 5-year survival.\"}]","High iNOS and IL-1β immunoreactivity are features of colitis-associated colorectal cancer tumors, but fail to predict 5-year survival | PDF",1790006617,23]